PCOS Renamed PMOS: What Women Need to Know About Symptoms, Causes and Treatment
A major international review has led to polycystic ovary syndrome (PCOS) being officially renamed polyendocrine metabolic ovarian syndrome (PMOS). Experts say the new name better reflects the condition’s complex hormonal and metabolic nature and aims to correct the long‑standing misconception that it is primarily a gynaecological disorder involving ovarian cysts.
PMOS affects an estimated 10–13% of women of reproductive age, yet many remain undiagnosed due to the wide variation in symptoms and the misleading terminology previously used.
What Is PMOS?
PMOS is a lifelong hormonal condition that can present differently from one woman to another. Symptoms often begin in late adolescence and may include:
- Irregular or absent periods
- Irregular ovulation
- Excess facial or body hair
- Acne
- Weight gain
- Hair thinning on the scalp
Despite the old name, PMOS does not involve ovarian cysts. The small fluid‑filled sacs seen on scans are actually follicles, which contain immature eggs. In PMOS, some follicles stop developing properly, meaning ovulation may not occur regularly.
What Causes PMOS?
PMOS is driven by a combination of hormonal and metabolic factors, including:
- Excess androgens, which are present in all women but elevated in PMOS
- An imbalance between follicle‑stimulating hormone (FSH) and luteinising hormone (LH)
- Insulin resistance, which increases androgen production
These factors can reinforce each other, creating a cycle where high insulin levels raise androgen levels, and high androgens worsen insulin resistance. Genetics, body weight and prenatal hormone exposure may also contribute.
How Is PMOS Diagnosed?
Diagnosis is based on the Rotterdam criteria, which require two of the following three:
- High androgen levels (clinical or biochemical)
- Irregular periods
- Polycystic‑appearing ovaries on ultrasound
This means a woman can be diagnosed with PMOS without having polycystic‑appearing ovaries or without irregular periods.
How Common Is It?
The World Health Organization estimates that up to 70% of women with PMOS are unaware they have it. Prevalence varies globally, with higher rates in some regions such as South Asia.
How Does PMOS Affect Women’s Health?
PMOS is a lifelong condition that can affect different aspects of health at different stages of life. It is associated with:
- Difficulty conceiving due to irregular ovulation
- Irregular or prolonged bleeding
- High cholesterol
- Increased risk of endometrial cancer
- Higher risk of type 2 diabetes and high blood pressure
- Increased likelihood of cardiovascular disease later in life
- Weight gain and difficulty losing weight
- Sleep apnoea
- Higher rates of depression, anxiety and eating disorders
Women with PMOS may burn fewer calories after eating, making weight management more challenging.
How Is PMOS Managed?
There is no cure, but symptoms can be managed depending on a woman’s priorities and stage of life. Management options include:
- Hormonal contraception to regulate periods and reduce androgen levels
- Ovulation‑inducing medications for women trying to conceive
- Lifestyle changes to improve insulin sensitivity
- Weight‑loss medications, with new treatments currently being studied
Treatment plans are tailored to the symptoms causing the most difficulty at the time.
Why the Name Has Changed
The term “polycystic ovary syndrome” has long been considered misleading. Many women with the condition do not have polycystic‑appearing ovaries, and the condition does not involve cysts. The old name also suggested the problem was confined to the ovaries, when PMOS affects multiple hormonal and metabolic systems.
The new name — polyendocrine metabolic ovarian syndrome — highlights the condition’s broader impact on women’s health and aims to improve understanding, diagnosis and long‑term care.




